Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Gynecology

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 74 articles:
HTML format



Single Articles


    July 2022
  1. HAAKENSTAD A, Angelino O, Irvine CMS, Bhutta ZA, et al
    Measuring contraceptive method mix, prevalence, and demand satisfied by age and marital status in 204 countries and territories, 1970-2019: a systematic analysis for the Global Burden of Disease Study 2019.
    Lancet. 2022;400:295-327.
    PubMed     Abstract available


  2. PRADHAN MR
    Contraceptive mix and informed choice.
    Lancet. 2022;400:255-257.
    PubMed    


  3. JAFFE S
    "Chaos" for patients and providers after US abortion ruling.
    Lancet. 2022;400:85-86.
    PubMed    


  4. HIAM L, Mateescu I, Spiegel P
    Improving access to contraception and abortion in Romania in the context of the conflict in Ukraine.
    Lancet. 2022 Jul 8. pii: S0140-6736(22)01275.
    PubMed    


  5. JAFFE S
    Federal abortion rights end, but not legal challenges.
    Lancet. 2022;400:13-14.
    PubMed    


    June 2022
  6. DASHRAATH P, Nielsen-Saines K, Mattar C, Musso D, et al
    Guidelines for pregnant individuals with monkeypox virus exposure.
    Lancet. 2022 Jun 21. pii: S0140-6736(22)01063.
    PubMed    


  7. GIUDICE LC, As-Sanie S, Arjona Ferreira JC, Becker CM, et al
    Once daily oral relugolix combination therapy versus placebo in patients with endometriosis-associated pain: two replicate phase 3, randomised, double-blind, studies (SPIRIT 1 and 2).
    Lancet. 2022;399:2267-2279.
    PubMed     Abstract available


  8. SARASWAT L, Bhattacharya S
    Relugolix combination therapy for endometriosis pain.
    Lancet. 2022;399:2244-2245.
    PubMed    


  9. HOLT E
    Poland to introduce controversial pregnancy register.
    Lancet. 2022;399:2256.
    PubMed    


  10. THE LANCET
    Attitudes towards menopause: time for change.
    Lancet. 2022;399:2243.
    PubMed    


  11. O'BRIEN E, Rich M
    Obstetric violence in historical perspective.
    Lancet. 2022;399:2183-2185.
    PubMed    


  12. REED SD, Zhou X, Ichikawa L, Gatz JL, et al
    Intrauterine device-related uterine perforation incidence and risk (APEX-IUD): a large multisite cohort study.
    Lancet. 2022;399:2103-2112.
    PubMed     Abstract available


  13. BARTZ D
    Incidence of perforation with intrauterine devices.
    Lancet. 2022;399:2076-2077.
    PubMed    


    May 2022
  14. SCHAEDEL Z, Rymer J
    Menopause care and over the counter vaginal oestradiol.
    Lancet. 2022 May 31. pii: S0140-6736(22)00952.
    PubMed    


  15. JARDINE J, Harris T, Khalil A, van der Meulen J, et al
    Adverse pregnancy outcomes: biological essentialism versus embodied biology - Authors' reply.
    Lancet. 2022;399:2014.
    PubMed    


  16. RAVI K, Janiak E
    Adverse pregnancy outcomes: biological essentialism versus embodied biology.
    Lancet. 2022;399:2013-2014.
    PubMed    


  17. SASIENI P, Castanon A
    HPV vaccination and cervical cancer screening - Authors' reply.
    Lancet. 2022;399:1940.
    PubMed    


  18. BEWLEY S
    HPV vaccination and cervical cancer screening.
    Lancet. 2022;399:1939.
    PubMed    


  19. KAMAMOTO S, Murayama A, Hamaki T, Kusumi E, et al
    HPV vaccination and cervical cancer screening.
    Lancet. 2022;399:1939-1940.
    PubMed    


  20. JAFFE S
    Health organizations fear effects of US abortion ruling.
    Lancet. 2022;399:1854.
    PubMed    


  21. VOSS FO, van Beurden M, Jordanova ES
    Topical imiquimod as first-line treatment for vulvar intraepithelial neoplasia.
    Lancet. 2022;399:1755-1757.
    PubMed    


  22. TRUTNOVSKY G, Reich O, Joura EA, Holter M, et al
    Topical imiquimod versus surgery for vulvar intraepithelial neoplasia: a multicentre, randomised, phase 3, non-inferiority trial.
    Lancet. 2022;399:1790-1798.
    PubMed     Abstract available


  23. DASHRAATH P, Chen K, Htet ZW, Chan SY, et al
    Pre-eclampsia with paradoxical polyuria: diabetes insipidus in pregnancy.
    Lancet. 2022;399:1809.
    PubMed    


    April 2022
  24. MAKONI M
    Hope for access to abortion in Kenya.
    Lancet. 2022;399:1456.
    PubMed    


  25. CROSBIE EJ, Kitson SJ, McAlpine JN, Mukhopadhyay A, et al
    Endometrial cancer.
    Lancet. 2022;399:1412-1428.
    PubMed     Abstract available


    March 2022
  26. BOOTH A
    Activists welcome Colombia's decriminalisation of abortion.
    Lancet. 2022;399:899.
    PubMed    


  27. MANCA T, Baylis F, Munoz FM, Top KA, et al
    Prioritise research on vaccines for pregnant and breastfeeding women.
    Lancet. 2022;399:890-893.
    PubMed    


    February 2022
  28. PASHANKAR R, Prabulos AM, Feder HM Jr
    A woman pregnant with twins has fever, haemolysis, and thrombocytopenia caused by babesiosis: could be confused with HELLP syndrome.
    Lancet. 2022;399:e10.
    PubMed    


  29. KALAFAT E, Magee LA, von Dadelszen P, Heath P, et al
    COVID-19 booster doses in pregnancy and global vaccine equity.
    Lancet. 2022 Feb 18. pii: S0140-6736(22)00166.
    PubMed    


  30. GERSHENSON DM, Miller A, Brady WE, Paul J, et al
    Trametinib versus standard of care in patients with recurrent low-grade serous ovarian cancer (GOG 281/LOGS): an international, randomised, open-label, multicentre, phase 2/3 trial.
    Lancet. 2022;399:541-553.
    PubMed     Abstract available


  31. BLAGDEN SP
    Targeting MAPK in recurrent, low-grade serous ovarian cancer.
    Lancet. 2022;399:499-501.
    PubMed    


  32. CERDEIRA AS, Ismail L, Moore N, George B, et al
    Retroperitoneal leiomyomatosis: a benign outcome of power morcellation with potentially serious consequences.
    Lancet. 2022;399:554.
    PubMed    


    January 2022
  33. HUG L, You D, Blencowe H, Moran AC, et al
    Strengthening the reporting of stillbirths globally - Authors' reply.
    Lancet. 2022;399:142.
    PubMed    


  34. DAS AM, Janardhanan R
    Strengthening the reporting of stillbirths globally.
    Lancet. 2022;399:141.
    PubMed    


  35. JOOS O, Swiney C, Sferrazza L
    Strengthening the reporting of stillbirths globally.
    Lancet. 2022;399:140-141.
    PubMed    


    December 2021
  36. JAFFE S
    US Supreme Court expected to weaken abortion rights.
    Lancet. 2021;398:2137-2138.
    PubMed    


    November 2021
  37. SANSON C, Majer M, Pautier P, Gouy S, et al
    Unexplained uterine atrophy following neoadjuvant chemotherapy in fertility sparing management of cervical cancer.
    Lancet. 2021;398:e17.
    PubMed    


  38. FALCARO M, Castanon A, Ndlela B, Checchi M, et al
    The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study.
    Lancet. 2021 Nov 3. pii: S0140-6736(21)02178.
    PubMed     Abstract available


  39. CRUICKSHANK ME, Grigore M
    Cervical cancers avoided by HPV immunisation.
    Lancet. 2021 Nov 3. pii: S0140-6736(21)02396.
    PubMed    


  40. JARDINE J, Walker K, Gurol-Urganci I, Webster K, et al
    Adverse pregnancy outcomes attributable to socioeconomic and ethnic inequalities in England: a national cohort study.
    Lancet. 2021 Nov 1. pii: S0140-6736(21)01595.
    PubMed     Abstract available


    October 2021
  41. THE LANCET
    Abortion bans in the USA harm health equity.
    Lancet. 2021;398:1461.
    PubMed    


    August 2021
  42. HUG L, You D, Blencowe H, Mishra A, et al
    Global, regional, and national estimates and trends in stillbirths from 2000 to 2019: a systematic assessment.
    Lancet. 2021;398:772-785.
    PubMed     Abstract available


  43. ODENDAAL J, Quenby S
    Making miscarriage matter - Authors' reply.
    Lancet. 2021;398:745-746.
    PubMed    


  44. AGAMPODI S, Hettiarachchi A, Agampodi T
    Making miscarriage matter.
    Lancet. 2021;398:745.
    PubMed    


  45. LUCAS S, Knight M, Lucas N, Rodger A, et al
    Making miscarriage matter.
    Lancet. 2021;398:744-745.
    PubMed    


  46. CHONG K, Li W, Roberts I, Mol BW, et al
    Making miscarriage matter.
    Lancet. 2021;398:743-744.
    PubMed    


  47. KIGULI J, Kirunda R, Nabaliisa J, Nalwadda CK, et al
    Inadequate evidence on stillbirths: rethinking public health.
    Lancet. 2021;398:727-729.
    PubMed    


  48. EKECHI C
    Addressing inequality in fertility treatment.
    Lancet. 2021;398:645-646.
    PubMed    


  49. KALAFAT E, Magee LA, von Dadelszen P, O'Brien P, et al
    SARS-CoV-2 vaccination in pregnancy: a unique opportunity for equity.
    Lancet. 2021 Aug 11. pii: S0140-6736(21)01756.
    PubMed    


  50. ROMANIS EC, Parsons JA, Salter I, Hampton T, et al
    Safeguarding and teleconsultation for abortion.
    Lancet. 2021;398:555-558.
    PubMed    


  51. MIANI C, Razum O
    The fragility of abortion access in Europe: a public health crisis in the making.
    Lancet. 2021;398:485.
    PubMed    


    July 2021
  52. WARASNA B, Rajabi N, Mustafa B, Najjar A, et al
    Knowledge and attitude of Palestinian women to contraceptives: a cross-sectional study.
    Lancet. 2021;398 Suppl 1:S45.
    PubMed     Abstract available


  53. ISBEIH M, Venkateswaran M, Abbas E, Abu-Khader K, et al
    Gestational age recorded at delivery versus estimations using antenatal care data from the Electronic Maternal and Child Health Registry in the West Bank: a comparative analysis.
    Lancet. 2021;398 Suppl 1:S31.
    PubMed     Abstract available


  54. EL-QATRAWI KJ
    Effect of hypertension on pregnancy outcomes at UNRWA health centres in Gaza governorates: a comparative study.
    Lancet. 2021;398 Suppl 1:S26.
    PubMed     Abstract available


  55. BOGALE B, Morkrid K, O'Donnell B, Ghanem B, et al
    Development of a targeted client communication intervention for pregnant and post-partum women: a descriptive study.
    Lancet. 2021;398 Suppl 1:S18.
    PubMed     Abstract available


    May 2021
  56. CHAPPELL LC, Cluver CA, Kingdom J, Tong S, et al
    Pre-eclampsia.
    Lancet. 2021 May 27. pii: S0140-6736(20)32335.
    PubMed     Abstract available


  57. MENON U, Gentry-Maharaj A, Burnell M, Singh N, et al
    Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.
    Lancet. 2021 May 12. pii: S0140-6736(21)00731.
    PubMed     Abstract available


  58. HURWITZ LM, Pinsky PF, Trabert B
    General population screening for ovarian cancer.
    Lancet. 2021 May 12. pii: S0140-6736(21)01061.
    PubMed    


    April 2021
  59. THE LANCET
    Miscarriage: worldwide reform of care is needed.
    Lancet. 2021 Apr 26. pii: S0140-6736(21)00954.
    PubMed    


  60. COOMARASAMY A, Dhillon-Smith RK, Papadopoulou A, Al-Memar M, et al
    Recurrent miscarriage: evidence to accelerate action.
    Lancet. 2021 Apr 23. pii: S0140-6736(21)00681.
    PubMed     Abstract available


  61. COOMARASAMY A, Gallos ID, Papadopoulou A, Dhillon-Smith RK, et al
    Sporadic miscarriage: evidence to provide effective care.
    Lancet. 2021 Apr 23. pii: S0140-6736(21)00683.
    PubMed     Abstract available


  62. QUENBY S, Gallos ID, Dhillon-Smith RK, Podesek M, et al
    Miscarriage matters: the epidemiological, physical, psychological, and economic costs of early pregnancy loss.
    Lancet. 2021 Apr 23. pii: S0140-6736(21)00682.
    PubMed     Abstract available


  63. KADIWAR S, Smith JJ, Ledot S, Johnson M, et al
    Were pregnant women more affected by COVID-19 in the second wave of the pandemic?
    Lancet. 2021 Apr 14. pii: S0140-6736(21)00716.
    PubMed    


  64. LOCKMAN S, Brummel SS, Ziemba L, Stranix-Chibanda L, et al
    Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAA
    Lancet. 2021;397:1276-1292.
    PubMed     Abstract available


  65. GILLEECE Y, Krankowska D
    ART in pregnant women living with HIV.
    Lancet. 2021;397:1240-1241.
    PubMed    


    February 2021
  66. TAYLOR HS, Kotlyar AM, Flores VA
    Endometriosis is a chronic systemic disease: clinical challenges and novel innovations.
    Lancet. 2021;397:839-852.
    PubMed     Abstract available


    January 2021
  67. BOOTH A
    Honduras changes constitution to ban abortion.
    Lancet. 2021;397:360.
    PubMed    


  68. LHEUREUX S, Cristea MC, Bruce JP, Garg S, et al
    Adavosertib plus gemcitabine for platinum-resistant or platinum-refractory recurrent ovarian cancer: a double-blind, randomised, placebo-controlled, phase 2 trial.
    Lancet. 2021;397:281-292.
    PubMed     Abstract available


  69. BLAGDEN SP, Nicum S
    A source of hope for platinum-resistant ovarian cancer?
    Lancet. 2021;397:254-256.
    PubMed    


  70. BOOTH A
    Argentina to legalise elective abortion.
    Lancet. 2021;397:82.
    PubMed    


    November 2020
  71. GILBERT L, Miller K, Medeiros D, Tsatoumas M, et al
    A disease disregards anatomical planes: actinomycosis and an intrauterine device.
    Lancet. 2020;396:1766.
    PubMed    


  72. CAMERON ST, Glasier A, McDaid L, Radley A, et al
    Use of effective contraception following provision of the progestogen-only pill for women presenting to community pharmacies for emergency contraception (Bridge-It): a pragmatic cluster-randomised crossover trial.
    Lancet. 2020;396:1585-1594.
    PubMed     Abstract available


  73. MARSTON C, Sowemimo A
    Bridge-It trial-a step towards better contraception services.
    Lancet. 2020;396:1536-1537.
    PubMed    


    September 2020
  74. ALVES L
    Brazilian doctors condemn new rules on abortion.
    Lancet. 2020;396:808.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Gynecology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: